Literature DB >> 29631563

Alterations of serum macro-minerals and trace elements are associated with major depressive disorder: a case-control study.

Md Rabiul Islam1, Md Reazul Islam2, M M A Shalahuddin Qusar3, Mohammad Safiqul Islam4, Md Humayun Kabir5, G K M Mustafizur Rahman5, Md Saiful Islam2, Abul Hasnat2.   

Abstract

BACKGROUND: Major depressive disorder (MDD) is a mixed disorder with the highly irregular course, inconsistent response to treatment and has no well-known mechanism for the pathophysiology. Major causes of depression are genetic, neurobiological, and environmental. However, over the past few years, altered serum levels of macro-minerals (MM) and trace elements (TE) have been recognized as major causative factors to the pathogenesis of many mental disorders. The purpose of this study was to determine the serum levels of MM (calcium and magnesium) and TE (copper, iron, manganese, selenium, and zinc) in MDD patients and find out their associations with depression risk.
METHODS: This prospective case-control study recruited 247 patients and 248 healthy volunteers matched by age and sex. The serum levels of MM and TE were analyzed by atomic absorption spectroscopy (AAS). Statistical analysis was performed with independent sample t-tests and Pearson's correlation test.
RESULTS: We found significantly decreased concentrations of calcium and magnesium, iron, manganese, selenium, and zinc in MDD patients compared with control subjects (p < 0.05). But the concentration of copper was significantly increased in the patients than control subjects (p < 0.05). Data obtained from different inter-element relations in MDD patients and control subjects strongly suggest that there is a disturbance in the element homeostasis.
CONCLUSION: Our study suggests that altered serum concentrations of MM and TE are major contributing factors for the pathogenesis of MDD. Alterations of these elements in serum levels of MDD patients arise independently and they may provide a prognostic tool for the assessment of depression risk.

Entities:  

Keywords:  Case-control; Inter-element relations; Macro-minerals; Major depressive disorder; Trace elements

Mesh:

Substances:

Year:  2018        PMID: 29631563      PMCID: PMC5891975          DOI: 10.1186/s12888-018-1685-z

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


Background

Major depressive disorder (MDD) is accompanied by low self-esteem and loss of interest or pleasure in day to day activities that adversely affect a person’s professional and personal life [1]. As major depression gives the enormous burden on an individual’s life, extensive efforts have been made to explore the biological mechanisms of it [2]. Major depression has been considered as a multifactorial disorder with genetic, neurological, and environmental factors contributing to overall risk. However, the mechanisms of these risk factors are still unknown [3]. Macro-minerals (MM) and trace elements (TE) play a versatile role in the biological system ranging from regulating metabolic reactions to acting as antioxidants [4, 5]. Several studies have suggested that alterations of these elements in serum levels are linked with the etiology and pathophysiology of many mental disorders [4, 6–9], including major depression [10]. Calcium (Ca) is essential for activation of different enzymes and plays a vital role in neuromuscular excitability. Low Ca level in the blood serum causes fragility of hair and nails and can also lead to mood disorders and depression [11]. Thus the deficiency of this mineral in the human body is linked with several chronic diseases [12]. Magnesium (Mg) acts as a coenzyme for many enzymatic systems. Mg is considered as an important factor in the treatment of depression due to its regulatory effects on N-methyl-D-aspartate (NMDA) channels [11]. Chronic stress, alcohol abuse, a diet rich in carbohydrates and fats cause Mg deficiency in the human and prolonged deficiency of this mineral develops depression [13]. Copper (Cu) accumulates in the liver, muscles, skeletal system, and brain of the human. Our kidneys, liver, and coronary arteries can be damaged by the high concentration of Cu in blood serum. Although, many disorders occur in the circulatory system, nervous system, and digestive system due to the deficiency of Cu [14]. In the human body, iron (Fe) transports oxygen through hemoglobin [15]. Fe deficiency is manifested mainly in weakness due to the limiting of aerobic changes in muscles. Moreover, some authors associate a decrease in body temperature, low appetite, and restless leg syndrome with Fe deficiency [16, 17]. Manganese (Mn) is a crucial trace element for human health [18]. In the central nervous system (CNS), Mn is presents in several proteins and key enzymes which are associated with some neurodegenerative disorders [19-21]. Selenium (Se) is an essential nutrient required for the functioning of antioxidant defenses in the brain and nervous system [22]. Zinc (Zn) is considered as an important element in the human body and sufficient amount of Zn is required for nucleic acid and protein metabolism, cellular growth, division and functions [23]. Zn is an important modulator of the functioning of the central nervous system [24]. Moreover, major depression can be influenced by some specific metalloenzymatic reactions in the brain. Trace metals regulate a range of cellular metabolic reactions and some of them are responsible for the etiology of several neurological disorders [25]. Superoxide dismutase (SOD) is a metalloenzyme that contains metal ions in its structure [26]. In human, three types of SOD are present. SOD1 is cytoplasmic, SOD2 is mitochondrial and SOD3 is extracellular. SOD1 is a dimer while SOD2 and SOD3 are tetramers. SOD1 and SOD3 contain Cu and Zn, while SOD2 contain Mn at their reactive center [27]. CuZnSOD involved in defense against reactive oxygen species (ROS). MnSOD is an antioxidant enzyme that provides protection against free radicals [28]. Based on the above observations, the present study was undertaken to explore the associations of serum MM and TE levels with the risk of major depression on Bangladeshi population.

Methods

Study design and blood sample collection

This prospective case-control study enrolled 247 MDD patients and 248 healthy individuals. The patients were recruited from the department of psychiatry, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh but the controls were from different parts of Dhaka city matched by age, gender and body mass index (BMI) with the patients. A specialized psychiatrist diagnosed the cases and evaluated the controls according to the diagnostic and statistical manual of mental disorders, 5th edition (DSM-V). Detailed physical and neurological screenings were performed to diagnose the coexistence of other complications. The study subjects had no previous history of liver or kidney failure and had not been treated with any medication that could interfere with the concentrations of MM or TE. Patients with mental retardation and comorbid psychiatric illness were also excluded from this study. Additional exclusion criteria were alcohol and substance abuse or dependency, tardive dyskinesia related to neuroleptics, severe organic conditions, excessive obesity and presence of infectious diseases. Sociodemographic data were recorded by using pre-designed questionnaires. Different biographical features (height, weight) and BMI were also examined for both the cases and controls. Blood samples (5 ml) were collected from the cephalic vein of each participant after an overnight fast. The samples were allowed to clot for one hour at room temperature. After centrifugation at 3000 rpm for 15 min, serum samples were extracted from the collected blood samples, placed into microtubes and stored at − 80 °C until analysis.

Chemical and reagents

Analytical grade reagents were used for the study from the commercially available company. Standards of Ca, Mg, Cu, Fe, Mn, Se, and Zn were sourced from ABCR GmbH & Co. KG, Germany. Hydrochloric acid (37%) and nitric acid were purchased from Merck, Germany. Other supportive chemicals of recommended grade were supplied by clinical pharmacy and pharmacology department, University of Dhaka, Bangladesh.

Determination of macro-minerals and trace elements

Serum level of MM and TE were measured by both flame atomic absorption spectrometry (FAAS) and graphite furnace atomic absorption spectrometry (GFAAS) following the method described in our previous articles [29, 30]. Briefly, collected serum samples were diluted with deionized water 1:10 dilution. Different concentrations of minerals (0.5, 1.0, 2.0, 5.0 and 10.0 mg/L) were used to prepare the calibration curve. Finally, the concentrations of MM and TE were measured by reading the absorbances’ at 422.7, 285.2, 327.4, 248.3, 279.8, 196.0 and 213.9 nm for Ca, Mg, Cu, Fe, Mn, Se, and Zn, respectively. The standard solutions were run for every 10 test samples to confirm the test precision and quality. The limits of detection (LoDs) were established by analyzing five blank solutions. The σ value was estimated by Microsoft office excel 2010 program. LoDs were found as follows (μg/L): 40Ca-1.9, 24Mg-0.24, 63Cu-1.8, 56Fe-0.13, 55Mn-0.07, 77Se-0.04, and 66Zn-0.05. SpectrAA software package was used to calculate the concentrations of MM and TE in serum samples using calibration curve. The safety measures for both collection and subsequent management of serum samples were taken to avoid or decrease MM and TE contamination.

Statistical analysis

Serum levels of MM and TE were presented as the mean ± standard error mean (mean ± SEM) and compared between the cases and the controls with independent sample t-tests. Boxplot graphs were used to compare study parameters between the patient group and the control subjects. Correlations were established among different study parameters using Pearson’s correlation test. p < 0.05 was considered to be statistically significant. Statistical analysis was performed using SPSS statistical software, version 20.0 (Armonk, NY: IBM Corp.)

Results

Anthropometric and demographic profile of the study population

The study population was categorized based on their socioeconomic conditions, biophysical characteristics and smoking habit. Socioeconomic data of MDD patients and control subjects have been shown in Table 1 where female comprised the highest percentage of both MDD patients and control subjects than the male. It was found that most of the patients were literate (87%) and nonsmoker (73%). BMI values were normal for 84% patients and 78% control subjects. Among all MDD patients, 38% were very poor and 79% had average monthly family income ≤25 k Bangladeshi taka (KBDT). Only 7% patients had monthly family income above 40 KBDT. Statistical analysis showed that the differences of age, education, occupation, BMI, income and smoking habit were not significant between the groups (p > 0.05).
Table 1

Anthropometric and demographic profile of the study population

ParametersPatients (n = 247)Controls (n = 248)p value
n %Mean ± SEM n %Mean ± SEM
Age in years
 18–24582354220.576
 25–34783233.03 ± 0.693793233.55 ± 0.608
 35–4465267430
 45–6046194117
Gender
 Female15663147590.193
 Male913710141
BMI (kg/m2)
 Below 18.5 (CED)23925100.193
 18.5–25 (normal)2088422.82 ± 0.1611947823.15 ± 0.191
 Above 25 (obese)1662912
Education
 Illiterate321326100.958
 Can read only47195121
 Secondary31133514
 Higher secondary63266727
 Graduate and above74306928
Occupation
 Service2292180.673
 Business31132912
 Student55226928
 Others103429739
 Jobless36153213
Monthly income in KBDT
 Below 10943859240.413
 10–251014119.28 ± 0.899973920.33 ± 0.911
 26–4034147530
 Above 40187177
Smoking habit
 Nonsmoker18073190770.352
 Smoker67275823

CED chronic energy deficiency, KBDT kilo Bangladeshi taka. **p < 0.05 (Significant difference between patient and control groups at 95% confidence interval)

Anthropometric and demographic profile of the study population CED chronic energy deficiency, KBDT kilo Bangladeshi taka. **p < 0.05 (Significant difference between patient and control groups at 95% confidence interval)

Serum levels of macro-minerals and trace elements

The mean serum concentrations of MM and TE for study population were presented in Table 2. Serum levels of Ca, Mg, Fe, Mn, Se, and Zn were found significantly decreased in MDD patients than control subjects (p < 0.05). But the concentration of Cu was significantly higher in the patient group (p > 0.05). The changes of serum MM and TE levels for cases and controls were presented in Figs. 1 and 2.
Table 2

Serum level of macro-minerals and trace elements in the study population

Elements (mg/L)Values (Mean ± SEM)
Patient groupControl groupReference rangeap value*
Ca94.91 ± 0.85105.06 ± 1.0590–110p < 0.05
Mg20.37 ± 0.2821.85 ± 0.3418–36p < 0.05
Cu1.39 ± 0.031.01 ± 0.020.6–1.4p < 0.05
Fe1.02 ± 0.021.30 ± 0.031.1–1.3p < 0.05
Mn1.00 ± 0. 011.17 ± 0.010.1–2.9p < 0.05
Se0.03 ± 0.0020.07 ± 0.0030.06–0.11p < 0.05
Zn0.92 ± 0.021.09 ± 0.020.6–1.2p < 0.05

*p < 0.05 (Significant difference between patient and control groups at 95% confidence interval)

a Reference values are given in milligrams per liter unit from the handbook on metals in clinical and analytical chemistry [53, 54]

Fig. 1

Changes in serum levels of macro-minerals in the study population. Boxplot showing the median, maximum and minimum value range. a Calcium, b: Magnesium

Fig. 2

Changes in serum levels of trace elements in the study population. Boxplot showing the median, maximum and minimum value range. a Zinc, b Copper, c Iron, d Manganese, e Selenium

Serum level of macro-minerals and trace elements in the study population *p < 0.05 (Significant difference between patient and control groups at 95% confidence interval) a Reference values are given in milligrams per liter unit from the handbook on metals in clinical and analytical chemistry [53, 54] Changes in serum levels of macro-minerals in the study population. Boxplot showing the median, maximum and minimum value range. a Calcium, b: Magnesium Changes in serum levels of trace elements in the study population. Boxplot showing the median, maximum and minimum value range. a Zinc, b Copper, c Iron, d Manganese, e Selenium

Correlation study

Pearson’s correlation was used to establish inter-element relationships between the patients and controls for the investigated elements and presented in Table 3. Among all established relationships, patient group showed significantly negative correlations between Mn and Zn (r = − 0.184, p = 0.004), Mn and Cu (r = − 0.171, p = 0.007), Cu and Se (r = − 0.175, p = 0.006), statistically significant positive correlations were also observed between Mn and Mg (r = 0.155, p = 0.015), Mg and Se (r = 0.145, p = 0.023). Control group showed statistically significant (p < 0.05) negative correlations between Mn and Cu (r = − 0.275, p < 0.001), Cu and Mg (r = − 0.240, p < 0.001). All other positive and negative correlations between MM and TE were not found statistically significant for both of the study groups. Study parameters were not found significantly correlated with age and BMI of the study population.
Table 3

Correlation study among various research parameters in patient and control groups

Correlation parametersPatient groupControl group
r p r p
Fe and Mn−0.0310.630−0.0210.743
Fe and Zn0.0250.6980.0030.963
Fe and Cu0.0450.479< 0.0010.999
Fe and Ca−0.0700.2720.0060.919
Fe and Mg−0.0320.6190.0490.438
Fe and Se−0.1210.0580.0170.788
Mn and Zn−0.1840.004a0.0860.178
Mn and Cu−0.1710.007a−0.275< 0.001a
Mn and Ca0.0410.518−0.0300.641
Mn and Mg0.1550.0150.266< 0.001a
Mn and Se0.0590.357−0.0060.927
Zn and Cu0.0790.219< 0.0010.995
Zn and Ca−0.0350.5890.0720.260
Zn and Mg0.0320.613−0.0420.506
Zn and Se−0.0120.8520.0470.458
Cu and Ca−0.0430.5050.0930.145
Cu and Mg0.0780.220−0.240< 0.001a
Cu and Se−0.1750.006a−0.0080.905
Ca and Mg−0.0180.774−0.0040.952
Ca and Se−0.0040.944−0.0310.623
Mg and Se0.1450.023−0.0510.424

r = Correlation co-efficient; p = Significance; Negative values specify opposite correlation

a Correlation is significant at 0.05 level (two-tailed)

Correlation study among various research parameters in patient and control groups r = Correlation co-efficient; p = Significance; Negative values specify opposite correlation a Correlation is significant at 0.05 level (two-tailed)

Discussion

To the best of our knowledge, this is the first ever study on Bangladeshi patients to find out the association of serum MM and TE levels with MDD. The required amounts of MM and TE are essential for maintaining proper healthy life. The present study explored the associations of MM and TE with the risk of major depression, demonstrating that alterations of serum MM and TE levels are associated with the increased risk of MDD. This generally happens when usual neurological physiology is troubled [31]. Several studies have shown that lower levels of serum Ca and Mg can cause various symptoms e.g. depression, anxiety, behavior, and personality changes [32]. One study showed that the significant deficiency of Ca was found in depression [33]. Other studies reported that serum concentrations of Mg were found substantially reduced in depressed patients [34, 35]. Another study revealed that Mg rich diet reduces the depressive symptoms [36]. The severity of depression is significantly influenced by the serum levels of Mg which confirms the involvement of Mg in the pathogenesis of depression [37]. In our current study, we found significantly lower levels of serum Ca and Mg in MDD patients compared to control subjects (p < 0.05). Thus this downregulation of serum MM levels may be involved in the pathogenesis of MDD. The average concentration of serum Cu was found higher in depressed patients by 21% than healthy controls [38]. In our study, we also found the higher concentration of Cu in MDD patients compared with the control subjects (p < 0.05). Fe plays a major role in the development of the central nervous system (CNS). Moreover, it plays a crucial role in the development of depression as fatigue is caused by Fe deficiency. The current study found that the serum levels of Fe were reduced significantly in MDD patients which are supported by previous study results [39]. Low levels of Mn cause depression by increasing auto-immune reactions and macrocytosis [40]. In our present study, we found the significantly lower concentration of Mn in MDD patients compared with the control subjects (p < 0.05). Another valuable element is Se and any deficiency of this element causes the glutathione peroxidase dysfunction which is an enzyme that protects oxidative damage [41]. Also, Se modulates the status of many neurotransmitters [42]. Lower Se concentration is a risk factor for depression via antioxidant pathways [43]. According to our study, Se concentrations were significantly lower in MDD patients compared with the controls (p < 0.05). This evidence suggests that Se deficiency contributes to the pathogenesis of MDD as it prevents oxidative damage. Zn deficiency in humans is relatively rare but it occurs during the emotional stress and some disease conditions e.g. giardiasis, diarrhea, acute pancreatitis, and chronic renal failure. Several studies have suggested that prolonged Zn deficiency causes neuropsychiatric disorders such as depression and lack of concentration [43-45]. These observations are consistent with our present study result where a significantly decreased level of serum Zn was found in MDD patients (p < 0.05). Nearly 7.6% patients suffering from psychiatric disorder have nutritional problems [46]. Serum concentrations of MM and TE are known to be influenced by dietary factors. The effects of diet on serum level of MM such as Ca and Mg are sparse [47]. Serum levels of Fe and Zn are especially affected by diet [48]. Serum level of Se could be affected by the low Se containing foodstuffs [49]. Deficiencies of Cu and Mn in the serum level are unusual due to a wide variety of dietary sources [50]. Pharmacotherapy is also a considerable factor that influences the serum levels of MM and TE in MDD patients. Serum Cu level is influenced by acute antidepressant therapy such as escitalopram and reboxetine reduced and imipramine increased serum Cu level [51]. Decreased serum Zn concentration can be normalized after successful antidepressant therapy e.g. citalopram increases serum Zn level [52]. At the end of our discussion, we can give some outline about lifestyle and diet as interventional events for MDD. According to our study findings, we can propose diet, current pharmacotherapy, and lifestyle as considerable factors for the proper treatment of MDD. We did not investigate the impact of dietary supplementation, current pharmacotherapy, and lifestyle on our study parameters that were the main drawback of our study. Therefore, this is a preliminary study and further investigation with more homogenous samples is required to support our findings. In spite of these limitations, the present study has some significant advantages. The first strength is the large study population match on age, sex and residential areas of patients and healthy controls. Another one is the simultaneous determination of all macro and micro elements under the same experimental conditions.

Conclusion

The present study illustrates that MDD patients have reduced serum concentrations of MM and TE except for Cu compared with healthy volunteers. So these findings suggest the possible involvement of depleted serum MM and TE in the pathogenesis of depression. It was found that there was no significant correlation of serum MM and TE with age and BMI of the patient group. The reduced serum MM and TE may have an influence on the development of MDD. We thus recommend the altered serum levels of MM and TE are associated with the risk of MDD which may require further study.
  46 in total

Review 1.  Iron and copper metabolism.

Authors:  Miguel Arredondo; Marco T Núñez
Journal:  Mol Aspects Med       Date:  2005 Aug-Oct

Review 2.  A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

Authors:  Michael Maes; Piotr Galecki; Yong Seun Chang; Michael Berk
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-05-12       Impact factor: 5.067

3.  Plasma magnesium and calcium in depression.

Authors:  D Frizel; A Coppen; V Marks
Journal:  Br J Psychiatry       Date:  1969-12       Impact factor: 9.319

4.  Regional specificity of manganese accumulation and clearance in the mouse brain: implications for manganese-enhanced MRI.

Authors:  B Grünecker; S F Kaltwasser; A C Zappe; B T Bedenk; Y Bicker; V I Spoormaker; C T Wotjak; M Czisch
Journal:  NMR Biomed       Date:  2012-11-20       Impact factor: 4.044

5.  Effect of lipid peroxidation, antioxidants, macro minerals and trace elements on eczema.

Authors:  Mohammad Nurul Amin; Kaniz Fatema Liza; Md Shahid Sarwar; Jamiuddin Ahmed; Md Tareek Adnan; Manjurul Islam Chowdhury; Mohammad Zahid Hossain; Mohammad Safiqul Islam
Journal:  Arch Dermatol Res       Date:  2015-05-13       Impact factor: 3.017

Review 6.  Systems genetics analysis of iron regulation in the brain.

Authors:  Leslie C Jellen; John L Beard; Byron C Jones
Journal:  Biochimie       Date:  2009-04-22       Impact factor: 4.079

7.  Rapid recovery from major depression using magnesium treatment.

Authors:  George A Eby; Karen L Eby
Journal:  Med Hypotheses       Date:  2006-03-20       Impact factor: 1.538

8.  Comparative analysis of serum manganese, zinc, calcium, copper and magnesium level in panic disorder patients.

Authors:  Zabun Nahar; Mohammad Abul Kalam Azad; Md Ashrafur Rahman; Mohammad Arifur Rahman; Wasimul Bari; Sheikh Nazrul Islam; Md Saiful Islam; Abul Hasnat
Journal:  Biol Trace Elem Res       Date:  2009-07-07       Impact factor: 3.738

Review 9.  Selenium intake, mood and other aspects of psychological functioning.

Authors:  David Benton
Journal:  Nutr Neurosci       Date:  2002-12       Impact factor: 4.994

10.  Analysis of Relations Between the Level of Mg, Zn, Ca, Cu, and Fe and Depressiveness in Postmenopausal Women.

Authors:  Małgorzata Szkup; Anna Jurczak; Aleksandra Brodowska; Agnieszka Brodowska; Iwona Noceń; Dariusz Chlubek; Maria Laszczyńska; Beata Karakiewicz; Elżbieta Grochans
Journal:  Biol Trace Elem Res       Date:  2016-07-30       Impact factor: 3.738

View more
  20 in total

1.  Iron Aggravates the Depressive Phenotype of Stressed Mice by Compromising the Glymphatic System.

Authors:  Shanshan Liang; Yan Lu; Zexiong Li; Shuai Li; Beina Chen; Manman Zhang; Binjie Chen; Ming Ji; Wenliang Gong; Maosheng Xia; Alexei Verkhratsky; Xu Wu; Baoman Li
Journal:  Neurosci Bull       Date:  2020-06-24       Impact factor: 5.203

2.  Total and ionized calcium and magnesium are significantly lowered in drug-naïve depressed patients: effects of antidepressants and associations with immune activation.

Authors:  Arafat Hussein Al-Dujaili; Hussein Kadhem Al-Hakeim; Ahmed Jasim Twayej; Michael Maes
Journal:  Metab Brain Dis       Date:  2019-07-10       Impact factor: 3.584

Review 3.  The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in Psychiatric and Neurodegenerative Disorders: Potential Pathogenetic Mechanism and Therapeutic Implications.

Authors:  Yutaka Nakagawa; Shizuo Yamada
Journal:  Cell Mol Neurobiol       Date:  2022-05-30       Impact factor: 5.046

4.  Effects of quercetin on the alterations of serum elements in chronic unpredictable mild stress-induced depressed rats.

Authors:  Tong Guan; Can Cao; Yali Hou; Yaru Li; Xinchen Wei; Siqi Li; Siqi Jia; Xiujuan Zhao
Journal:  Biometals       Date:  2021-03-20       Impact factor: 2.949

5.  Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder.

Authors:  Sadia Anjum; M M A Shalahuddin Qusar; Mohammad Shahriar; Sardar Mohammad Ashraful Islam; Mohiuddin Ahmed Bhuiyan; Md Rabiul Islam
Journal:  Ther Adv Psychopharmacol       Date:  2020-04-28

6.  Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics.

Authors:  Mike C Jentsch; Huibert Burger; Marjolein B M Meddens; Lian Beijers; Edwin R van den Heuvel; Marcus J M Meddens; Robert A Schoevers
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923

7.  Dietary intake of fish and n-3 polyunsaturated fatty acids and risk of postpartum depression: a nationwide longitudinal study - the Japan Environment and Children's Study (JECS).

Authors:  Kei Hamazaki; Kenta Matsumura; Akiko Tsuchida; Haruka Kasamatsu; Tomomi Tanaka; Mika Ito; Hidekuni Inadera
Journal:  Psychol Med       Date:  2019-09-19       Impact factor: 7.723

8.  Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression.

Authors:  Jakub Słupski; Wiesław Jerzy Cubała; Natalia Górska; Anita Słupska; Maria Gałuszko-Węgielnik
Journal:  Brain Sci       Date:  2020-12-11

9.  Association of Selenium Intake and Development of Depression in Brazilian Farmers.

Authors:  Tatiana Lourençoni Ferreira de Almeida; Glenda Blaser Petarli; Monica Cattafesta; Eliana Zandonade; Olivia Maria de Paula Alves Bezerra; Kelly Guimães Tristão; Luciane Bresciani Salaroli
Journal:  Front Nutr       Date:  2021-05-20

10.  Serum Concentrations of Vitamin D, Calcium, Phosphorus and Trace Minerals in Adults and Children with Haemophilia A: Association with Disease Severity, Quality of Life, Joint Health and Functional Status.

Authors:  Amir Abbasnezhad; Mehdi Habibi; Babak Abdolkarimi; Soodabeh Zare; Ezatollah Fazeli Moghadam; Razieh Choghakhori
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.